4D-QSAR investigation and pharmacophore identification of pyrrolo[2,1-c][1,4]benzodiazepines using electron conformational–genetic algorithm method

References

• L.H. Hurley, DNA and associated targets for drug design, J. Med. Chem. 32 (1989), pp. 2027–2033.
   PubMed Web of Science ®Google Scholar
• D.E. Thurston, Advances in the study of pyrrolo[2,1-c][1,4]benzodiazepine (PBD) antitumour antibiotics in Molecular Aspects of Anticancer Drug–DNA Interactions, S. Neidle and MJ Waring, eds., MacMillan Press, London, 1993, pp. 54–88.
   Google Scholar
• M.D. Tendler and S. Korman, “Refuin”: A non-cytotoxic carcinostatic compound proliferated by a thermophilic actinomycete, Nature 199 (1963), p. 501.
   PubMed Web of Science ®Google Scholar
• L.H. Hurley and R.L. Petrusek, Proposed structure of the anthramycin–DNA adduct, Nature. 282 (1979), pp. 529–531.
   PubMed Web of Science ®Google Scholar
• D.J. Abraham, The history of quantitative structure activity relationships, in Burger's Medicinal Chemistry and Drug Discovery, C.D. Selassie, ed., John Wiley and Sons Publishers, New York, NY, 2003, pp. 1–48.
   Google Scholar
• E.X. Esposito, A.J. Hopfinger, and J.D. Madura, Methods for applying the quantitative structure-activity relationship paradigm, Meth. Mol. Biol. 275 (2004), pp. 131–213.
   PubMedGoogle Scholar
• S.J. Free and J. Wilson, A mathematical contribution to structure activity studies, J. Med. Chem. 7 (1964), pp. 395–399.
   PubMed Web of Science ®Google Scholar
• C. Hansch and T. Fujita, ρ-σ-π Analysis: A method for the correlation of biological activity and chemical structure, J. Am. Chem. Soc. 86 (1964), pp. 1616–1626.
   Web of Science ®Google Scholar
• R. Cramer, D. Patterson, and J. Bunce, Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins, J. Am. Chem. Soc. 110 (1988), pp. 5959–5967.
   PubMed Web of Science ®Google Scholar
• G. Klebe, Comparative molecular similarity indices analysis: CoMSIA, in 3D QSAR Drug Design, Vol. 3, H. Kubinyi, G. Folkers, and Y.C. Martin, eds., Kluwer Academic Publishers, Newyork, 1998, pp. 87–104.
   Google Scholar
• A.J. Hopfinger, S. Wang, J.S. Tokarski, B. Jin, M. Albuquerque, P.J. Madhav, and C. Duraiswami, Construction of 3D-QSAR models using the 4D-QSAR analysis formalism, J. Am. Chem. Soc. 119 (1997), pp. 10509–10524.
   Web of Science ®Google Scholar
• A. Vedani and M. Dobler, 5D-QSAR: The key for simulating induced fit?, J. Med. Chem. 45 (2002), pp. 2139–2149.
   PubMed Web of Science ®Google Scholar
• A. Vedani, M. Dobler, and M.A. Lill, Combining protein modeling and 6D-QSAR-Simulating the binding of structurally diverse ligands to the estrogen receptor, J. Med. Chem. 48 (2005), pp. 3700–3703.
   PubMed Web of Science ®Google Scholar
• J. Polanski, Receptor dependent multidimensional QSAR for modeling drug-receptor interactions, Curr. Med. Chem. 16 (2009), pp. 3243–3257.
   PubMed Web of Science ®Google Scholar
• A. Kamal, E.V. Bharathi, M.J. Ramaiah, D. Dastagiri, J.S. Reddy, A. Viswanath, and F. Sultana, S.N.C.V.L. Pushpavalli, M. Pal-Bhadra, H.K. Srivastava, G.N. Sastry, A. Juvekar, S. Sen, and S. Zingde, Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates: Design, synthesis and biological evaluation as potential anticancer agents, Bioorg. Med. Chem. 18 (2010), pp. 526–542.
   PubMed Web of Science ®Google Scholar
• D. Antonow and D.E. Thurston, Synthesis of DNA-interactive pyrrolo[2,1-c][1,4]benzodiazepines (PBDs), Chem. Rev. 111 (2011), pp. 2815–2864.
   PubMed Web of Science ®Google Scholar
• L. Cipolla, A.C. Araújo, C. Airoldi, and D. Bini, Pyrrolo[2,1-c][1,4]benzodiazepine as a scaffold for the design and synthesis of anti-tumour drugs, Anticancer Agents Med. Chem. 9 (2009), pp. 1–31.
   PubMed Web of Science ®Google Scholar
• Y. Ohtake, A. Naito, H. Hasegawa, K. Kawano, D. Morizono, M. Taniguchi, Y. Tanaka, H. Matsukawa, K. Naito, T. Oguma, Y. Ezure, and Y. Tsuriya, Novel vasopressin V2 receptor-selective antagonists, pyrrolo[2,1-a]quinoxaline and pyrrolo[2,1-c][1,4]benzodiazepine derivatives, Bioorg. Med. Chem. 7 (1999), pp. 1247–1254.
   PubMed Web of Science ®Google Scholar
• C. Paulussen, K. de Wit, G. Boulet, P. Cos, L. Meerpoel, and L. Maes, Pyrrolo[1,2- α][1,4]benzodiazepines show potent in vitro antifungal activity and significant in vivo efficacy in a Microsporum canis dermatitis model in guinea pigs, J. Antimicrob. Chemother. 69 (2014), pp. 1608–1610.
   PubMed Web of Science ®Google Scholar
• D. Antonow, M. Kaliszczak, G.D. Kang, M. Coffils, A.C. Tiberghien, N. Cooper, T. Barata, S. Heidelberger, C.H. James, M. Zloh, T.C. Jenkins, A.P. Reszka, S. Neidle, S.M. Guichard, D.I. Jodrell, J.A. Hartley, P.W. Howard, and D.E. Thurston, Structure-activity relationships of monomeric C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine (PBD) antitumor agents, J. Med. Chem. 53 (2010), pp. 2927–2941.
   PubMed Web of Science ®Google Scholar
• E. Sarıpınar, N. Geçen, K. Şahin, and E. Yanmaz, Pharmacophore identification and bioactivity prediction for triaminotriazine derivatives by electron conformational-genetic algorithm QSAR method, Eur. J. Med. Chem. 45 (2010), pp. 4157–4168.
   PubMed Web of Science ®Google Scholar
• I.B. Bersuker and A.S. Dimoglo, The electron-topological approach to the QSAR problem, in Reviews in Computational Chemistry, K.B. Lipkowitz and D.B. Boyd, eds., John Wiley and Sons Publisher Inc, New Jersey, 1991, pp. 423–460.
   Google Scholar
• I.B. Bersuker, Pharmacophore identification and quantitative bioactivity prediction using the electron-conformational method, Curr. Pharm. Des. 9 (2003), pp. 1575–1606.
   PubMed Web of Science ®Google Scholar
• I.B. Bersuker, S. Bahçeci, and J.E. Boggs, Improved electron-conformational method of pharmacophore identification and bioactivity prediction. Application to angiotensin converting enzyme inhibitors, J. Chem. Inf. Comput. Sci. 40 (2000), pp. 1363–1376.
   PubMedGoogle Scholar
• N. Sukumar, G. Prabhu, and P. Saha, Applications of genetic algorithms in QSAR/QSPR Modeling, in Applications of Metaheuristics in Process Engineering, J. Valadi and P. Siarry, eds., Springer International Publishing, Switzerland, 2014, pp. 315–324.
   Google Scholar
• E. Yanmaz, E. Sarıpınar, K. Şahin, N. Geçen, and F. Çopur, 4D-QSAR analysis and pharmacophore modeling: Electron conformational-genetic algorithm approach for penicillins, Bioorg. Med. Chem. 19 (2011), pp. 2199–2210.
   PubMed Web of Science ®Google Scholar
• K. Şahin, E. Sarıpınar, E. Yanmaz, and N. Geçen, Quantitative bioactivity prediction and pharmacophore identification for benzotriazines derivatives by electron conformational-genetic algorithm QSAR method, SAR QSAR Environ. Res. 22 (2011), pp. 217–238.
   PubMed Web of Science ®Google Scholar
• N. Geçen, E. Sarıpınar, E. Yanmaz, and K. Sahin, Application of electron conformational–genetic algorithm approach to 1,4-dihydropyridines as calcium channel antagonists: Pharmacophore identification and bioactivity prediction, J. Mol. Model. 18 (2012), pp. 65–82.
   PubMed Web of Science ®Google Scholar
• L. Akyüz, E. Sarıpınar, E. Kaya, and E. Yanmaz, 4D-QSAR study of HEPT derivatives by electron conformational-genetic algorithm method, SAR QSAR Environ Res. 23 (2012), pp. 409–433.
   PubMed Web of Science ®Google Scholar
• L. Akyüz and E. Sarıpınar, Conformation depends on 4D-QSAR analysis using EC–GA method: Pharmacophore identification and bioactivity prediction of TIBOs as non-nucleoside reverse transcriptase inhibitors, J. Enzyme Inhib. Med. Chem. 28 (2013), pp. 776–791.
   PubMed Web of Science ®Google Scholar
• Spartan'10; Wavefunction, Inc.: Irvine, CA, 2011.
   Google Scholar
• I.B. Bersuker, QSAR without arbitrary descriptors: The electron-conformational method, J. Comput. Aided. Mol. Des. 22 (2008), pp. 423–430.
   PubMed Web of Science ®Google Scholar
• A.S. Dimoglo, P.F. Vlad, N.M. Shvets, and M.N. Coltsa, Electronic-topolocigal investigations of the relationship between chemical structure and ambergris odor, New J. Chem. 19 (1995), pp. 1217–1226.
   Web of Science ®Google Scholar
• E. Sarıpınar, Y. Güzel, Ş. Patat, İ. Yıldırım, Y. Akçamur, and A.S. Dimoglo, Electron-topological investigation of structure-antitubercular activity relationship of thiosemicarbazone derivatives, Arzneimittelforschung 46 (1996), pp. 824–828.
   PubMed Web of Science ®Google Scholar
• I.B. Bersuker, S. Bahçeci, J.E. Boggs, and R.S. Pearlman, An electron conformational method of identification of pharmacophore and anti-pharmacophore shielding: Application to rice blast activity, J. Comput. Aided. Mol. Des. 13 (1999), pp. 419–434.
   PubMed Web of Science ®Google Scholar
• MATLAB (ver 7.0), The MathWorks Inc, 3 Apple Hill Drive, Natick, MA 01760-2098.
   Google Scholar
• J.H. Holland, Adaptation in Artificial and Natural Systems, University of Michigan Press, Michigan, Ann Arbor, 1975.
   Google Scholar
• J. Devillers, Principles of QSAR and Drug Design: Genetic Algorithms in Molecular Modeling, Academic Press, Lyon, 1996.
   Google Scholar
• G. Schüürmann, R.U. Ebert, J. Chen, B. Wang, and R. Kuhne, External validation and prediction employing the predictive squared correlation coefficient - test set activity mean vs training set activity mean, J. Chem. Inf. Model. 48 (2008), pp. 2140–2145.
   PubMed Web of Science ®Google Scholar
• V. Consonni, D. Ballabio, and R. Todeschini, Comments on the definition of the Q2 parameter for QSAR validation, J. Chem. Inf. Model. 49 (2009), pp. 1669–1678.
   PubMed Web of Science ®Google Scholar
• N. Chirico and P. Gramatica, Real external predictivity of QSAR models: How to evaluate it? Comparison of different validation criteria and proposal of using the concordance correlation coefficient, J. Chem. Inf. Model. 51 (2011), pp. 2320–2335.
   PubMed Web of Science ®Google Scholar
• Al H. Makkouk and I.B. Bersuker, and J.E. Boggs, Quantitative drug activity prediction for inhibitors of human breast carcinoma, Int. J Pharm. Med. 18 (2004), pp. 81–89.
   Google Scholar
• J.G. Topliss and R.P. Edwards, Chance factors in studies of quantitative structure-activity relationships, J. Med. Chem. 22 (1979), pp. 1238–1244.
   PubMed Web of Science ®Google Scholar
• J. Wan, L. Zhang, and G. Yang, Quantitative structure–activity relationships for phenyl triazolinones of protoporphyrinogen oxidase inhibitors: A density functional theory study, J. Comp. Chem. 25 (2004), pp. 1827–1832.
   PubMed Web of Science ®Google Scholar
• W. Long and P. Liu, Quantitative structure activity relationship modeling for predicting radiosensitization effectiveness of nitroimidazole compounds, J. Radiat. Res. 51 (2010), pp. 563–572.
   PubMed Web of Science ®Google Scholar
• R. Todeschini and V. Consonni, Molecular Descriptors for Chemoinformatics, Vol. 41, Wiley-VCH, Weinheim, 2009, pp. 625–626.
   Google Scholar
• A. Golbraikh and A. Tropsha, Beware of q2!, J. Mol. Graph. Model. 20 (2002), pp. 269–276.
   PubMed Web of Science ®Google Scholar